Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 XOMA Appoints Chief Commercial Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

XOMA Appoints Chief Commercial Officer

Klein brings 25 years of experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Tom Klein has been appointed chief commercial officer at XOMA Corp. In this newly created position, he reports to chief executive officer John Varian. Mr. Klein has more than 25 years of successful brand commercialization leadership, with an expertise in commercializing biologics. Mr. Klein joins the company from Genentech, where he was vice president, business unit head of Virology and Specialty Care.
 
“We created an executive-level position for commercial operations for two reasons. First, we are at the point where we are ready to begin building XOMA’s launch strategy and commercialization plans for gevokizumab. The importance of creating the sales and marketing plan for our first XOMA-developed product cannot be underestimated. We will build on Tom’s vast experience to develop a launch program that maximizes the commercial potential of gevokizumab,” said Mr. Varian.
 
He added, “The second reason was to fully integrate market analyses into our clinical development decisions. Tom will draw on his years of experience and to provide our team with the most accurate information that will guide our second, third and fourth gevokizumab indications. The team and I are looking forward to working closely with Tom to ensure gevokizumab is a commercial success.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters